Bluefin Capital Management, LLC Liquidia Corp Transaction History
Bluefin Capital Management, LLC
- $1.3 Billion
- Q3 2024
A detailed history of Bluefin Capital Management, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Bluefin Capital Management, LLC holds 39,658 shares of LQDA stock, worth $422,357. This represents 0.03% of its overall portfolio holdings.
Number of Shares
39,658
Previous 23,100
71.68%
Holding current value
$422,357
Previous $277,000
42.96%
% of portfolio
0.03%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding LQDA
# of Institutions
171Shares Held
44.3MCall Options Held
1.55MPut Options Held
1.52M-
Patient Square Capital LP Menlo Park, CA7.18MShares$76.5 Million26.66% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$45.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$36.7 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$35 Million0.17% of portfolio
-
Findell Capital Management LLC New York, NY3.19MShares$34 Million16.08% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $685M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...